Takeda Pharmaceutical Company Limited Other Finance Income
Takeda Pharmaceutical Company Limited (TAK) reported Other Finance Income of JPY 6.78 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherFinanceIncome · last filed 2025-06-25
| Period end | Other Finance Income 12 month | Other Finance Income 12 month as first filed |
|---|---|---|
| 2025-03-31 | 6.78B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 1.88B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 7.50B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 10.46B JPY 20-F · filed 2024-06-26 | 11.50B JPY 20-F · filed 2022-06-29 |
| 2021-03-31 | 11.38B JPY 20-F · filed 2023-06-28 | 8.08B JPY 20-F · filed 2021-06-29 |
| 2020-03-31 | 728.00M JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 603.00M JPY 20-F · filed 2021-06-29 | |
| 2018-03-31 | 2.67B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 1.48B JPY 20-F · filed 2019-06-27 |